Skip to main content

Advertisement

Table 3 Estimated mean percentages of new patients treated with defined anti-thrombotic therapies

From: Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians

  When you see new patients with atrial fibrillation, for what percentage do you administer the following anti-thrombotic therapies?
  All (n = 331) Geriatricians (n = 51) Family doctors (n = 151) Internal Medicine Specialists (n = 129) P-value§
Warfarin 72.6% 76.4% 71.9% 71.9% 0.28
no antithrombotic therapy 5.4% 4.9% 5.3% 5.8% 0.21
Aspirin 20.7% 19.8% 20.4% 21.5% 0.24
Plavix (Clopidogrel) 4.2% 3.8% 5.2% 3.2% 0.11
Other 2.9% 1.6% 2.7% 3.6% 0.46
  1. §Kruskal-Wallis; P < 0.05.